(-)-anisomycin multiple interactions EXP 6480464 [Anisomycin co-treated with 1 more ... CTD PMID:23539296 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2C65 mRNA CTD PMID:36331819 (E,E)-germacrone decreases activity ISO CYP2C9 (Homo sapiens) 6480464 germacrone results in decreased activity of CYP2C9 protein CTD PMID:23850985 (R)-lipoic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 (S)-naringenin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 naringenin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 (S)-naringenin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 naringenin results in decreased activity of CYP2C9 protein CTD PMID:29753067 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 1 more ... CTD PMID:9733665 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of CYP2C65 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CYP2C65 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CYP2C65 mRNA CTD PMID:22206623 1,4-naphthoquinone increases abundance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased abundance of 1 and 4-naphthoquinone CTD PMID:16243959 1-naphthol increases abundance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased abundance of 1-naphthol CTD PMID:16243959 1-naphthyl isothiocyanate multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP2C9 mRNA CTD PMID:27344345 14,15-EET increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 14 more ... CTD PMID:12675279 14,15-EET multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased chemical synthesis of 14 more ... CTD PMID:12675279 17alpha-ethynylestradiol increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of Ethinyl Estradiol CTD PMID:15304426 17beta-estradiol multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [ESR1 protein co-treated with MED25 protein co-treated with Estradiol] results in increased activity of CYP2C9 protein more ... CTD PMID:21768169 and PMID:27273787 17beta-estradiol increases activity ISO CYP2C9 (Homo sapiens) 6480464 Estradiol results in increased activity of CYP2C9 protein CTD PMID:22837389 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2C9 mRNA CTD PMID:16985168 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2C65 mRNA CTD PMID:28213091 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity EXP 6480464 Verapamil results in decreased activity of CYP2C9 protein CTD PMID:18420780 2-n-Propyl-4-pentenoic acid increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 2-propyl-4-pentenoic acid CTD PMID:16945988 2-nitroanisole increases oxidation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased oxidation of 2-nitroanisole CTD PMID:21218109 2-tert-butylhydroquinone increases expression ISO CYP2C9 (Homo sapiens) 6480464 2-tert-butylhydroquinone results in increased expression of CYP2C9 mRNA and 2-tert-butylhydroquinone results in increased expression of CYP2C9 protein CTD PMID:24830941 2-tert-butylhydroquinone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP2C9 mRNA] more ... CTD PMID:24830941 3,3',5-triiodo-L-thyronine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Triiodothyronine promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] CTD PMID:14557374 4'-hydroxydiclofenac multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac more ... CTD PMID:24104198 more ... 4'-hydroxydiclofenac increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 4'-hydroxydiclofenac CTD PMID:12401345 and PMID:15155557 4,4'-sulfonyldiphenol increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of bisphenol S CTD PMID:27213244 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 more ... CTD PMID:29285606 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases activity ISO CYP2C9 (Homo sapiens) 6480464 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene results in increased activity of CYP2C9 protein CTD PMID:29285606 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Cisapride results in decreased activity of CYP2C9 protein CTD PMID:15306208 4-hydroxy-3-(2-hydroxy-3-oxo-1-phenylbutyl)-2H-chromen-2-one multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 10-hydroxywarfarin binds to and results in decreased activity of CYP2C9 protein more ... CTD PMID:20429590 more ... 4-hydroxy-3-[1-(4-hydroxyphenyl)-3-oxobutyl]-2H-chromen-2-one multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 4'-hydroxywarfarin binds to and results in decreased activity of CYP2C9 protein more ... CTD PMID:20429590 more ... 4-Hydroxy-N-desmethyltamoxifen decreases activity ISO CYP2C9 (Homo sapiens) 6480464 4-hydroxy-N-desmethyltamoxifen results in decreased activity of CYP2C9 protein CTD PMID:29285606 4-hydroxycyclophosphamide increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 4-hydroxycyclophosphamide CTD PMID:24819615 4-hydroxyphenytoin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein results in increased hydroxylation of Phenytoin] which results in increased abundance of hydroxyphenytoin and Miconazole inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Phenytoin] which results in increased abundance of hydroxyphenytoin] CTD PMID:33961833 4-hydroxytolbutamide increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 4'-hydroxytolbutamide and CYP2C9 protein results in increased chemical synthesis of hydroxymethyltolbutamide CTD PMID:15155557 and PMID:21915887 4-hydroxytolbutamide multiple interactions EXP 6480464 [CYP2C65 protein results in increased metabolism of Tolbutamide] which results in increased chemical synthesis of 4'-hydroxytolbutamide CTD PMID:30503582 4-hydroxytolbutamide multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein results in increased metabolism of Tolbutamide] which results in increased chemical synthesis of 4'-hydroxytolbutamide more ... CTD PMID:21915887 and PMID:32198085 4-Hydroxyvalproic acid increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 4-hydroxyvalproate CTD PMID:16945988 4-isopropylphenol increases glutathionylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased glutathionylation of 4-isopropylphenol CTD PMID:23470418 4-methylimidazole multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 4-methylimidazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] CTD PMID:16081671 4-tert-Octylphenol increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene SNP results in increased susceptibility to 4-tert-octylphenol CTD PMID:23555028 5,7-dihydroxy-4'-methoxyflavone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 acacetin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 5-Hydroxyflavone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 5-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 5-Hydroxyvalproic acid increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 5-hydroxyvalproate CTD PMID:16945988 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Omeprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] CTD PMID:15258107 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole decreases activity EXP 6480464 Omeprazole results in decreased activity of CYP2C9 protein CTD PMID:18420780 5-methoxyindole decreases activity ISO CYP2C9 (Homo sapiens) 6480464 5-methoxyindole results in decreased activity of CYP2C9 protein CTD PMID:18420780 5-methyltryptamine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [5-methyltryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac CTD PMID:26599973 5-methyltryptamine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 5-methyltryptamine analog results in decreased activity of CYP2C9 protein CTD PMID:26599973 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases expression ISO CYP2C9 (Homo sapiens) 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:21768169 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:21768169 7,12-dimethyltetraphene increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased susceptibility to 9 more ... CTD PMID:20507880 7-hydroxyflavone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 7-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 7-hydroxyflavone decreases activity ISO CYP2C9 (Homo sapiens) 6480464 7-hydroxyflavone results in decreased activity of CYP2C9 protein CTD PMID:29753067 7-Hydroxywarfarin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 7-hydroxywarfarin results in decreased activity of CYP2C9 protein CTD PMID:20429590 7-Hydroxywarfarin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 10-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] more ... CTD PMID:19408964 more ... 7-Hydroxywarfarin increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 7-hydroxywarfarin CTD PMID:25986145 7-Hydroxywarfarin affects abundance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the abundance of 7-hydroxywarfarin CTD PMID:25986145 8'-apo-beta,psi-caroten-8'-al increases expression ISO CYP2C9 (Homo sapiens) 6480464 apocarotenal results in increased expression of CYP2C9 mRNA CTD PMID:17034753 8,9-EET increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 8 and 9-epoxyeicosatrienoic acid CTD PMID:12675279 8,9-EET multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased chemical synthesis of 8 and 9-epoxyeicosatrienoic acid] CTD PMID:12675279 acenaphthylene increases oxidation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased oxidation of acenaphthylene CTD PMID:25642975 acenocoumarol increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Acenocoumarol CTD PMID:16878445 acenocoumarol increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased susceptibility to Acenocoumarol CTD PMID:16869821 acenocoumarol affects response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the susceptibility to Acenocoumarol and CYP2C9 gene SNP affects the susceptibility to Acenocoumarol CTD PMID:15213846 more ... acenocoumarol affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Acenocoumarol CTD PMID:11918509 acetone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Acetone promotes the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] CTD PMID:10611138 acetonitrile multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 acetonitrile promotes the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] CTD PMID:10611138 acetylsalicylic acid affects response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 polymorphism affects the susceptibility to Aspirin CTD PMID:21966608 aconitine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Amiodarone results in decreased activity of CYP2C9 protein] which results in decreased chemical synthesis of Aconitine metabolite and [CYP2C9 protein results in increased metabolism of Aconitine] which results in increased chemical synthesis of 16-O-demethylaconitine CTD PMID:21277363 aconitine increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Aconitine CTD PMID:21277363 adefovir decreases activity ISO CYP2C9 (Homo sapiens) 6480464 adefovir results in decreased activity of CYP2C9 protein CTD PMID:17162464 adefovir pivoxil decreases activity ISO CYP2C9 (Homo sapiens) 6480464 adefovir dipivoxil results in decreased activity of CYP2C9 protein CTD PMID:17162464 afimoxifene increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of afimoxifene CTD PMID:29285606 aflatoxin B1 affects expression ISO CYP2C9 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of CYP2C9 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO CYP2C9 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of CYP2C9 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of CYP2C9 mRNA CTD PMID:27153756 aflatoxin B1 multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Aflatoxin B1 CTD PMID:23397584 aflatoxin B1 increases expression ISO CYP2C9 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of CYP2C9 mRNA CTD PMID:21994236 alizarin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 alizarin results in decreased activity of CYP2C9 protein CTD PMID:33438235 all-trans-4-hydroxyretinoic acid increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 4-hydroxyretinoic acid CTD PMID:10874126 all-trans-4-oxoretinoic acid increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of 4-oxoretinoic acid CTD PMID:10874126 all-trans-retinoic acid decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Tretinoin results in decreased activity of CYP2C9 protein CTD PMID:18420780 all-trans-retinoic acid increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of Tretinoin CTD PMID:10874126 all-trans-retinoic acid decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Tretinoin results in decreased expression of CYP2C9 mRNA CTD PMID:16985168 Aloe emodin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 aloe emodin results in decreased activity of CYP2C9 protein CTD PMID:33438235 alpha-linolenic acid decreases activity ISO CYP2C9 (Homo sapiens) 6480464 alpha-Linolenic Acid results in decreased activity of CYP2C9 protein CTD PMID:16978661 alpha-linolenic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of [alpha-Linolenic Acid co-treated with NADP] CTD PMID:16978661 alpha-naphthoflavone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 alpha-naphthoflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 amiodarone decreases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in decreased susceptibility to Amiodarone CTD PMID:26477383 amiodarone increases expression ISO CYP2C9 (Homo sapiens) 6480464 Amiodarone results in increased expression of CYP2C9 mRNA CTD PMID:36586010 amiodarone decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Amiodarone results in decreased activity of CYP2C9 protein CTD PMID:16449812 amiodarone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Amiodarone results in decreased activity of CYP2C9 protein] which results in decreased chemical synthesis of 16-O-demethylaconitine more ... CTD PMID:14557374 more ... amitriptyline multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Amitriptyline CTD PMID:23397584 amodiaquine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Amodiaquine results in decreased activity of CYP2C9 protein CTD PMID:11124226 Ancriviroc decreases ethylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in decreased ethylation of Ancriviroc CTD PMID:16012074 Ancriviroc affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Ancriviroc CTD PMID:16012074 andrographolide decreases expression ISO CYP2C9 (Homo sapiens) 6480464 andrographolide results in decreased expression of CYP2C9 mRNA CTD PMID:19041297 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP2C9 mRNA] CTD PMID:24830941 anthracene-1,8,9-triol decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Anthralin results in decreased activity of CYP2C9 protein CTD PMID:33438235 apigenin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Apigenin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 apigenin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Apigenin results in decreased activity of CYP2C9 protein CTD PMID:29753067 arachidonic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of [Arachidonic Acid co-treated with NADP] and Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased metabolism of Arachidonic Acid] CTD PMID:12675279 and PMID:16978661 arachidonic acid decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Arachidonic Acid results in decreased activity of CYP2C9 protein CTD PMID:16978661 arachidonic acid increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Arachidonic Acid CTD PMID:12675279 aristolochic acid A increases expression ISO CYP2C9 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of CYP2C9 mRNA CTD PMID:33212167 atazanavir sulfate multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP2C9 mRNA CTD PMID:33819548 Auriculasin increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of auriculasin CTD PMID:31515991 Auriculasin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 auriculasin results in decreased activity of CYP2C9 protein CTD PMID:31515991 Auriculasin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased metabolism of auriculasin] CTD PMID:31515991 Avasimibe multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 avasimibe results in increased activity of and results in increased expression of CYP2C9 protein and avasimibe results in increased expression of and results in increased activity of CYP2C9 protein CTD PMID:15333513 and PMID:19202563 Avasimibe decreases activity ISO CYP2C9 (Homo sapiens) 6480464 avasimibe results in decreased activity of CYP2C9 protein CTD PMID:15333513 baicalein multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 baicalein inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 baicalein decreases activity ISO CYP2C9 (Homo sapiens) 6480464 baicalein results in decreased activity of CYP2C9 protein CTD PMID:29753067 barnidipine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 mepirodipine results in decreased activity of CYP2C9 protein CTD PMID:10805063 benfuracarb increases oxidation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased oxidation of benfuracarb CTD PMID:24016712 benidipine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 benidipine results in decreased activity of CYP2C9 protein CTD PMID:10805063 and PMID:27732883 benzbromarone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Benzbromarone analog binds to and results in decreased activity of CYP2C9 protein more ... CTD PMID:10613612 more ... benzbromarone affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Benzbromarone CTD PMID:18020424 and PMID:21321060 benzbromarone affects binding ISO CYP2C9 (Homo sapiens) 6480464 Benzbromarone binds to CYP2C9 protein CTD PMID:12814975 benzo[a]pyrene decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CYP2C9 mRNA CTD PMID:32234424 beta-carotene increases expression ISO CYP2C9 (Homo sapiens) 6480464 beta Carotene results in increased expression of CYP2C9 mRNA CTD PMID:17034753 beta-naphthoflavone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 beta-Naphthoflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 beta-naphthoflavone decreases expression ISO CYP2C9 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of CYP2C9 mRNA CTD PMID:16985168 and PMID:33263786 bilirubin IXalpha multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 IL1B protein inhibits the reaction [Bilirubin results in increased expression of CYP2C9 mRNA] CTD PMID:15382119 bilirubin IXalpha increases expression ISO CYP2C9 (Homo sapiens) 6480464 Bilirubin results in increased expression of CYP2C9 mRNA CTD PMID:15382119 biochanin A decreases activity ISO CYP2C9 (Homo sapiens) 6480464 biochanin A results in decreased activity of CYP2C9 protein CTD PMID:26278343 bisphenol A increases expression ISO CYP2C9 (Homo sapiens) 6480464 bisphenol A results in increased expression of CYP2C9 mRNA CTD PMID:26196221 bisphenol A multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [ESR1 protein co-treated with MED25 protein co-treated with bisphenol A] results in increased activity of CYP2C9 protein and [ESR1 protein co-treated with MED25 protein co-treated with bisphenol A] results in increased expression of CYP2C9 mRNA CTD PMID:27273787 bisphenol A increases glutathionylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased glutathionylation of bisphenol A and CYP2C9 protein results in increased glutathionylation of bisphenol A metabolite CTD PMID:23470418 bisphenol A increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of bisphenol A and CYP2C9 protein results in increased hydroxylation of bisphenol A metabolite CTD PMID:23470418 bisphenol F increases glutathionylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased glutathionylation of 4 more ... CTD PMID:23470418 bisphenol F increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of 4 and 4'-bisphenol F CTD PMID:23470418 bortezomib affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Bortezomib CTD PMID:15764713 bromfenac multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Acetylcysteine affects the reaction [CYP2C9 protein results in increased hydroxylation of bromfenac] and Glutathione affects the reaction [CYP2C9 protein results in increased hydroxylation of bromfenac] CTD PMID:31815452 bromfenac increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of bromfenac CTD PMID:31815452 Bufuralol increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of bufuralol CTD PMID:9429232 busulfan multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [GSTM1 protein co-treated with CYP2C9 protein] results in increased susceptibility to [Busulfan co-treated with Cyclophosphamide] CTD PMID:28744217 butanal increases expression ISO CYP2C9 (Homo sapiens) 6480464 butyraldehyde results in increased expression of CYP2C9 mRNA CTD PMID:26079696 butyric acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in increased expression of CYP2C9 mRNA] and Butyric Acid inhibits the reaction [Oxalic Acid results in increased expression of CYP2C9 mRNA] CTD PMID:37414240 C.I. Natural Red 20 decreases activity ISO CYP2C9 (Homo sapiens) 6480464 shikonin results in decreased activity of CYP2C9 protein CTD PMID:28941798 cadmium atom increases expression ISO CYP2C9 (Homo sapiens) 6480464 Cadmium results in increased expression of CYP2C9 protein CTD PMID:11551516 caffeine decreases activity EXP 6480464 Caffeine results in decreased activity of CYP2C9 protein CTD PMID:18420780 calciol increases expression ISO CYP2C9 (Homo sapiens) 6480464 Cholecalciferol metabolite results in increased expression of CYP2C9 CTD PMID:11991950 calciol decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Cholecalciferol results in decreased activity of CYP2C9 protein CTD PMID:18420780 cannabidiol decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Cannabidiol results in decreased activity of CYP2C9 protein CTD PMID:24667653 cannabidiol multiple interactions EXP 6480464 [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CYP2C65 mRNA CTD PMID:33096940 capsaicin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Capsaicin results in decreased activity of CYP2C9 protein CTD PMID:22375877 captan increases expression EXP 6480464 Captan results in increased expression of CYP2C65 mRNA CTD PMID:31558096 carbamazepine increases activity ISO CYP2C9 (Homo sapiens) 6480464 Carbamazepine results in increased activity of CYP2C9 protein CTD PMID:19202563 carbamazepine increases expression ISO CYP2C9 (Homo sapiens) 6480464 Carbamazepine results in increased expression of CYP2C9 mRNA CTD PMID:17112801 carbamazepine affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Carbamazepine CTD PMID:15286053 carbamazepine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Carbamazepine CTD PMID:23397584 carfentanil increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of carfentanil CTD PMID:33652071 carnosic acid decreases expression EXP 6480464 salvin results in decreased expression of CYP2C65 protein CTD PMID:35926579 Carnosol decreases activity ISO CYP2C9 (Homo sapiens) 6480464 carnosol results in decreased activity of CYP2C9 protein CTD PMID:34592323 celecoxib increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Celecoxib CTD PMID:17681167 and PMID:19082874 CGP 52608 multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYP2C9 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C9 mRNA more ... CTD PMID:33819548 chlorpromazine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Chlorpromazine results in decreased activity of CYP2C9 protein CTD PMID:15135088 chlorpromazine decreases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in decreased susceptibility to Chlorpromazine CTD PMID:26477383 chlorpromazine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Chlorpromazine CTD PMID:23397584 chlorpyrifos affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Chlorpyrifos CTD PMID:16190164 cholesterol decreases activity EXP 6480464 Cholesterol results in decreased activity of CYP2C9 protein CTD PMID:18420780 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYP2C65 mRNA CTD PMID:20938992 chrysin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 chrysin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 chrysophanol decreases activity ISO CYP2C9 (Homo sapiens) 6480464 chrysophanic acid results in decreased activity of CYP2C9 protein CTD PMID:27633141 cimetidine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Cimetidine results in decreased activity of CYP2C9 protein CTD PMID:19909766 cimetidine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP2C9 protein] CTD PMID:19909766 cisapride decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Cisapride results in decreased activity of CYP2C9 protein CTD PMID:15306208 cisplatin affects response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the susceptibility to Cisplatin CTD PMID:16217747 clofibric acid increases expression ISO CYP2C9 (Homo sapiens) 6480464 Clofibric Acid results in increased expression of CYP2C9 mRNA CTD PMID:15802389 clopidogrel multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene affects the reaction [CYP2C19 gene affects the susceptibility to clopidogrel] and CYP2C9 protein results in increased oxidation of and results in increased cleavage of clopidogrel metabolite CTD PMID:19170597 more ... clopidogrel decreases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene SNP results in decreased metabolism of clopidogrel CTD PMID:17900275 clopidogrel affects response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene SNP affects the susceptibility to clopidogrel CTD PMID:17900275 clothianidin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [clothianidin co-treated with thiacloprid] results in increased expression of CYP2C9 protein CTD PMID:32201337 clotrimazole multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Clotrimazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] and Clotrimazole results in increased activity of and results in increased expression of CYP2C9 protein CTD PMID:16081671 and PMID:19202563 clotrimazole affects binding ISO CYP2C9 (Homo sapiens) 6480464 Clotrimazole binds to CYP2C9 protein and Clotrimazole binds to CYP2C9 protein alternative form CTD PMID:29621561 clozapine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Clozapine results in decreased activity of CYP2C9 protein] which results in increased susceptibility to Phenytoin and [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Clozapine CTD PMID:17961958 and PMID:23397584 clozapine increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Clozapine CTD PMID:18809730 cocaine decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Cocaine results in decreased expression of CYP2C9 mRNA and Cocaine results in decreased expression of CYP2C9 protein CTD PMID:16188404 copper atom multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein co-treated with Copper] results in increased activity of Eugenol CTD PMID:15576237 copper(0) multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein co-treated with Copper] results in increased activity of Eugenol CTD PMID:15576237 corticosterone increases expression ISO CYP2C9 (Homo sapiens) 6480464 Corticosterone results in increased expression of CYP2C9 mRNA CTD PMID:35301062 coumarin affects response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein polymorphism affects the susceptibility to coumarin CTD PMID:23582453 coumarin affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein polymorphism affects the metabolism of coumarin CTD PMID:17849045 coumarins multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Amiodarone promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] more ... CTD PMID:14557374 coumarins increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Coumarins CTD PMID:14557374 cumene hydroperoxide affects oxidation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the oxidation of cumene hydroperoxide CTD PMID:17478480 cyclophosphamide increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased susceptibility to Cyclophosphamide CTD PMID:10991840 cyclophosphamide decreases activity EXP 6480464 Cyclophosphamide results in decreased activity of CYP2C9 protein CTD PMID:18420780 cyclophosphamide multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [GSTM1 protein co-treated with CYP2C9 protein] results in increased susceptibility to [Busulfan co-treated with Cyclophosphamide] and Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased susceptibility to Cyclophosphamide] CTD PMID:10991840 and PMID:28744217 cyclophosphamide increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Cyclophosphamide CTD PMID:11377097 and PMID:24819615 cyclophosphamide increases activity ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 results in increased activity of Cyclophosphamide CTD PMID:9241661 cyclosporin A decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CYP2C9 mRNA CTD PMID:20106945 and PMID:27989131 cyclosporin A multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of CYP2C9 mRNA CTD PMID:33819548 cylindrospermopsin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 cylindrospermopsin results in decreased activity of CYP2C9 protein CTD PMID:30905859 cypermethrin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 cypermethrin results in decreased activity of CYP2C9 protein CTD PMID:18420780 cypermethrin increases expression ISO CYP2C9 (Homo sapiens) 6480464 cypermethrin results in increased expression of CYP2C9 mRNA CTD PMID:22310298 cyproconazole decreases activity ISO CYP2C9 (Homo sapiens) 6480464 cyproconazole results in decreased activity of CYP2C9 protein CTD PMID:21251949 cyproconazole affects binding ISO CYP2C9 (Homo sapiens) 6480464 cyproconazole binds to CYP2C9 protein alternative form CTD PMID:29621561 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP2C65 mRNA CTD PMID:22334560 and PMID:23970803 dabrafenib decreases activity ISO CYP2C9 (Homo sapiens) 6480464 dabrafenib results in decreased activity of CYP2C9 protein CTD PMID:34780725 daidzein decreases activity ISO CYP2C9 (Homo sapiens) 6480464 daidzein results in decreased activity of CYP2C9 protein CTD PMID:18420780 and PMID:29753067 dapsone affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Dapsone CTD PMID:12920490 dapsone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Dapsone promotes the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen] more ... CTD PMID:15130760 dapsone decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Dapsone results in decreased activity of CYP2C9 protein CTD PMID:11124226 delavirdine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Delavirdine results in decreased activity of CYP2C9 protein CTD PMID:11225565 deoxycholic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C9 mRNA more ... CTD PMID:33819548 desipramine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Desipramine results in decreased activity of CYP2C9 protein CTD PMID:15135088 dexamethasone increases activity ISO CYP2C9 (Homo sapiens) 6480464 Dexamethasone results in increased activity of CYP2C9 protein CTD PMID:19202563 dexamethasone increases expression ISO CYP2C9 (Homo sapiens) 6480464 Dexamethasone results in increased expression of CYP2C9 mRNA CTD PMID:15802389 dexamethasone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Dexamethasone results in increased expression of and results in increased activity of CYP2C9 protein CTD PMID:15802389 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C65 mRNA CTD PMID:29950665 dextromethorphan decreases activity EXP 6480464 Dextromethorphan results in decreased activity of CYP2C9 protein CTD PMID:18420780 diarylheptanoid decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Diarylheptanoids results in decreased activity of CYP2C9 protein CTD PMID:23850985 diazinon multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of and results in increased activity of Diazinon CTD PMID:11708902 dibenz[a,h]anthracene multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein results in increased metabolism of 1 more ... CTD PMID:8638931 dibenz[a,h]anthracene increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of 1 more ... CTD PMID:8638931 diclofenac affects hydrolysis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the hydrolysis of Diclofenac CTD PMID:9698079 diclofenac decreases activity EXP 6480464 Diclofenac results in decreased activity of CYP2C9 protein CTD PMID:18420780 diclofenac increases hydrolysis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydrolysis of Diclofenac CTD PMID:9698079 diclofenac increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of Diclofenac CTD PMID:10975605 more ... diclofenac decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Diclofenac results in decreased activity of CYP2C9 protein CTD PMID:15135088 diclofenac affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Diclofenac CTD PMID:15801540 and PMID:16081671 diclofenac decreases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism results in decreased hydroxylation of Diclofenac CTD PMID:11455026 diclofenac increases oxidation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased oxidation of Diclofenac CTD PMID:17478480 diclofenac increases activity ISO CYP2C9 (Homo sapiens) 6480464 Diclofenac results in increased activity of CYP2C9 protein CTD PMID:15802386 diclofenac affects binding ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein binds to Diclofenac CTD PMID:15039296 diclofenac multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 1-aminobenzotriazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] more ... CTD PMID:12569440 more ... diclofenac increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 mRNA results in increased metabolism of Diclofenac and CYP2C9 protein results in increased metabolism of Diclofenac CTD PMID:12401345 more ... diclofenamide multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Dichlorphenamide promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] CTD PMID:14557374 difenoconazole affects binding ISO CYP2C9 (Homo sapiens) 6480464 difenoconazole binds to CYP2C9 protein and difenoconazole binds to CYP2C9 protein alternative form CTD PMID:29621561 dihydrocapsaicin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 dihydrocapsaicin results in decreased activity of CYP2C9 protein CTD PMID:22375877 dihydroergotamine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Dihydroergotamine results in decreased activity of CYP2C9 protein CTD PMID:18420780 dimemorfan increases oxidation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased oxidation of dimemorfan CTD PMID:19593786 dimethyl sulfoxide multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Dimethyl Sulfoxide co-treated with TGFB1 protein] results in decreased expression of CYP2C9 mRNA and [Dimethyl Sulfoxide co-treated with TGFB1 protein] results in decreased expression of CYP2C9 protein CTD PMID:35366062 diniconazole affects binding ISO CYP2C9 (Homo sapiens) 6480464 diniconazole binds to CYP2C9 protein alternative form CTD PMID:29621561 dioscin increases expression ISO CYP2C9 (Homo sapiens) 6480464 dioscin results in increased expression of CYP2C9 mRNA CTD PMID:29990575 diosmetin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 diosmetin results in decreased activity of CYP2C9 protein CTD PMID:28867436 dioxygen decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of CYP2C9 mRNA CTD PMID:19695866 dodecanoic acid increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of lauric acid CTD PMID:11455026 and PMID:9241660 dodecanoic acid decreases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism results in decreased hydroxylation of lauric acid CTD PMID:11455026 dopamine decreases activity EXP 6480464 Dopamine results in decreased activity of CYP2C9 protein CTD PMID:18420780 econazole multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Econazole binds to and results in decreased activity of CYP2C9 protein and Econazole binds to and results in decreased activity of CYP2C9 protein alternative form CTD PMID:29621561 efavirenz decreases activity ISO CYP2C9 (Homo sapiens) 6480464 efavirenz results in decreased activity of CYP2C9 protein CTD PMID:11225565 ellipticine increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein mutant form results in increased metabolism of ellipticine CTD PMID:22917556 emodin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Emodin results in decreased activity of CYP2C9 protein CTD PMID:27633141 and PMID:33438235 enilconazole decreases expression ISO CYP2C9 (Homo sapiens) 6480464 enilconazole results in decreased expression of CYP2C9 mRNA CTD PMID:32201337 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of CYP2C65 mRNA CTD PMID:22334560 and PMID:23970803 erythromycin A decreases activity EXP 6480464 Erythromycin results in decreased activity of CYP2C9 protein CTD PMID:18420780 estropipate multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 estropipate promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] CTD PMID:14557374 ethanol decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Ethanol results in decreased expression of CYP2C9 mRNA CTD PMID:31059573 ethanol increases expression ISO CYP2C9 (Homo sapiens) 6480464 Ethanol results in increased expression of CYP2C9 mRNA CTD PMID:35301062 eugenol multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein co-treated with Copper] results in increased activity of Eugenol CTD PMID:15576237 felbamate increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Felbamate CTD PMID:35786679 felodipine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Felodipine results in decreased activity of CYP2C9 protein CTD PMID:27732883 fenitrothion decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Fenitrothion results in decreased activity of CYP2C9 protein CTD PMID:20183062 and PMID:22634058 fenitrothion multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Fenitrothion inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] CTD PMID:22634058 fenvalerate increases expression ISO CYP2C9 (Homo sapiens) 6480464 fenvalerate results in increased expression of CYP2C9 mRNA CTD PMID:22310298 fimasartan increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of fimasartan CTD PMID:29596975 fimasartan increases oxidation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased oxidation of fimasartan CTD PMID:29596975 fimasartan increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of fimasartan CTD PMID:29596975 fipronil increases expression ISO CYP2C9 (Homo sapiens) 6480464 fipronil results in increased expression of CYP2C9 mRNA CTD PMID:27091632 fipronil multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2C9 mRNA CTD PMID:27091632 flavanone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 flavanone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 flavone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 flavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 flavonol multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 3-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 fluconazole decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Fluconazole results in decreased activity of CYP2C9 protein CTD PMID:15328084 more ... fluconazole multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Fluconazole results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac more ... CTD PMID:16081671 more ... fluorescein (lactone form) multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein and Sulfaphenazole inhibits the reaction [[CYP2C9 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein] CTD PMID:23850985 fluoxetine affects abundance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the abundance of Fluoxetine and CYP2C9 protein affects the abundance of Fluoxetine CTD PMID:14726986 and PMID:15094477 fluoxetine increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Fluoxetine CTD PMID:14726986 fluphenazine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Fluphenazine results in decreased activity of CYP2C9 protein CTD PMID:15135088 flurbiprofen multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 3' more ... CTD PMID:15130760 more ... flurbiprofen affects hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the hydroxylation of Flurbiprofen CTD PMID:15955872 flurbiprofen increases hydrolysis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydrolysis of Flurbiprofen CTD PMID:9698079 flurbiprofen affects hydrolysis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the hydrolysis of Flurbiprofen CTD PMID:9698079 flurbiprofen affects binding ISO CYP2C9 (Homo sapiens) 6480464 Flurbiprofen binds to CYP2C9 protein CTD PMID:21053930 flurbiprofen increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Flurbiprofen CTD PMID:11901091 more ... flurbiprofen increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein polymorphism results in increased hydroxylation of Flurbiprofen and CYP2C9 protein results in increased hydroxylation of Flurbiprofen CTD PMID:15130760 and PMID:21053930 flurbiprofen affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the metabolism of Flurbiprofen CTD PMID:11901091 more ... flutamide multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Flutamide CTD PMID:23397584 fluvastatin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 fluvastatin inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] CTD PMID:16081671 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 folpet increases expression EXP 6480464 folpet results in increased expression of CYP2C65 mRNA CTD PMID:31558096 galangin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 galangin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 genistein multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Genistein inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 genistein decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Genistein results in decreased activity of CYP2C9 protein CTD PMID:29753067 glipizide increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Glipizide CTD PMID:10208645 glipizide decreases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism results in decreased metabolism of Glipizide CTD PMID:10208645 glutathione multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac more ... CTD PMID:24246759 more ... glycochenodeoxycholic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C9 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C9 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C9 mRNA more ... CTD PMID:33819548 glyphosate decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Glyphosate results in decreased activity of CYP2C9 protein CTD PMID:20183062 hesperetin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 hesperetin results in decreased activity of CYP2C9 protein CTD PMID:29753067 HET0016 decreases activity ISO CYP2C9 (Homo sapiens) 6480464 HET0016 results in decreased activity of CYP2C9 protein CTD PMID:11375247 hydrogen peroxide increases abundance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased abundance of Hydrogen Peroxide CTD PMID:25061110 hyperforin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 hyperforin results in increased expression of and results in increased activity of CYP2C9 protein and NR1I2 protein affects the reaction [hyperforin results in increased expression of CYP2C9 mRNA] CTD PMID:14600250 and PMID:15100173 hyperforin increases expression ISO CYP2C9 (Homo sapiens) 6480464 hyperforin results in increased expression of CYP2C9 mRNA CTD PMID:14600250 more ... ibuprofen increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Ibuprofen CTD PMID:12464242 and PMID:17681167 ibuprofen multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Ibuprofen inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] CTD PMID:16081671 ibuprofen affects response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the susceptibility to Ibuprofen CTD PMID:25578229 ibuprofen affects binding ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein binds to Ibuprofen CTD PMID:15039296 ibuprofen affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 polymorphism affects the metabolism of Ibuprofen and CYP2C9 protein polymorphism affects the metabolism of Ibuprofen CTD PMID:12152005 and PMID:37406757 ibuprofen decreases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism results in decreased metabolism of Ibuprofen CTD PMID:15289789 and PMID:18694831 Icaritin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 icaritin results in decreased activity of CYP2C9 protein CTD PMID:29753067 ifosfamide increases activity ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 results in increased activity of Ifosfamide CTD PMID:9241661 ifosfamide increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased susceptibility to Ifosfamide CTD PMID:20507880 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYP2C65 mRNA CTD PMID:36331819 irbesartan increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of irbesartan CTD PMID:12359989 irbesartan decreases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism results in decreased susceptibility to irbesartan CTD PMID:12359989 irinotecan decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Irinotecan metabolite results in decreased activity of CYP2C9 protein CTD PMID:11901092 isocarbophos multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of and results in decreased sulfation of and affects the activity of isocarbophos CTD PMID:24752505 isoliquiritigenin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 isoliquiritigenin results in decreased activity of CYP2C9 protein CTD PMID:29753067 isoproturon decreases activity ISO CYP2C9 (Homo sapiens) 6480464 isoproturon results in decreased activity of CYP2C9 protein CTD PMID:18420780 Isradipine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Isradipine results in decreased activity of CYP2C9 protein CTD PMID:27732883 ivermectin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Ivermectin results in decreased activity of CYP2C9 protein CTD PMID:18420780 kaempferol multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 kaempferol inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 kaempferol decreases activity ISO CYP2C9 (Homo sapiens) 6480464 kaempferol results in decreased activity of CYP2C9 protein CTD PMID:29753067 ketoconazole decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Ketoconazole results in decreased expression of CYP2C9 mRNA CTD PMID:16608920 ketoconazole decreases activity EXP 6480464 Ketoconazole results in decreased activity of CYP2C9 protein CTD PMID:18420780 ketoconazole affects binding ISO CYP2C9 (Homo sapiens) 6480464 Ketoconazole binds to CYP2C9 protein and Ketoconazole binds to CYP2C9 protein alternative form CTD PMID:29621561 ketoconazole multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Ketoconazole affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] more ... CTD PMID:16081671 more ... ketoconazole decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Ketoconazole results in decreased activity of CYP2C9 protein CTD PMID:14709627 and PMID:15618748 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYP2C65 mRNA CTD PMID:20938992 lansoprazole increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of Lansoprazole CTD PMID:12975331 and PMID:8627562 lansoprazole multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Lansoprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] CTD PMID:15258107 lead(0) decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Lead results in decreased expression of CYP2C9 mRNA CTD PMID:19921347 leflunomide increases expression ISO CYP2C9 (Homo sapiens) 6480464 Leflunomide results in increased expression of CYP2C9 mRNA CTD PMID:30364229 Licochalcone A decreases activity ISO CYP2C9 (Homo sapiens) 6480464 licochalcone A results in decreased activity of CYP2C9 protein CTD PMID:26100226 linoleic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of [Linoleic Acid co-treated with NADP] CTD PMID:16978661 linoleic acid decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Linoleic Acid results in decreased activity of CYP2C9 protein CTD PMID:16978661 lipoic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 liquiritigenin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 liquiritigenin results in decreased activity of CYP2C9 protein CTD PMID:29753067 lithocholic acid decreases activity EXP 6480464 Lithocholic Acid results in decreased activity of CYP2C9 protein CTD PMID:18420780 losartan increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Losartan CTD PMID:19082874 more ... losartan increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of Losartan CTD PMID:25994031 losartan affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Losartan CTD PMID:20405111 and PMID:21321060 losartan multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene mutant form inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Losartan] and Resveratrol inhibits the reaction [CYP2C9 protein results in increased metabolism of Losartan] CTD PMID:20716633 and PMID:25994031 luteolin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Luteolin results in decreased activity of CYP2C9 protein CTD PMID:29753067 Luteolin 7-methyl ether decreases activity ISO CYP2C9 (Homo sapiens) 6480464 hydroxygenkwanin results in decreased activity of CYP2C9 protein CTD PMID:34843882 malathion decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Malathion results in decreased activity of CYP2C9 protein CTD PMID:20183062 and PMID:22634058 malathion multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Malathion inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] CTD PMID:22634058 mangiferin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 mangiferin results in decreased activity of CYP2C9 protein CTD PMID:22815239 manidipine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 manidipine results in decreased activity of CYP2C9 protein CTD PMID:10805063 Marrubiin increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of marrubiin CTD PMID:34431289 mefenamic acid increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of Mefenamic Acid CTD PMID:25372302 mefenamic acid increases oxidation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased oxidation of Mefenamic Acid CTD PMID:33259822 mefenamic acid increases glutathionylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased glutathionylation of Mefenamic Acid analog CTD PMID:25372302 mefenamic acid increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Mefenamic Acid CTD PMID:12464242 Melarsoprol decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Melarsoprol results in decreased activity of CYP2C9 protein CTD PMID:11124226 mephenytoin decreases activity EXP 6480464 Mephenytoin results in decreased activity of CYP2C9 protein CTD PMID:18420780 methotrexate decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Methotrexate results in decreased expression of CYP2C9 mRNA CTD PMID:24449571 methoxsalen decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Methoxsalen results in decreased activity of CYP2C9 protein CTD PMID:18420780 methoxychlor multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C19 protein co-treated with CYP2C9 protein] results in decreased methylation of Methoxychlor CTD PMID:15486075 methoxychlor decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Methoxychlor results in decreased activity of CYP2C9 protein CTD PMID:18420780 methoxychlor decreases methylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in decreased methylation of Methoxychlor CTD PMID:12167570 and PMID:9733665 Methysticin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 methysticin results in decreased activity of CYP2C9 protein CTD PMID:35583123 Methysticin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 methysticin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] more ... CTD PMID:35583123 miconazole multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Miconazole inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Phenytoin] which results in increased abundance of hydroxyphenytoin] more ... CTD PMID:16081671 and PMID:33961833 miconazole affects binding ISO CYP2C9 (Homo sapiens) 6480464 Miconazole binds to CYP2C9 protein and Miconazole binds to CYP2C9 protein alternative form CTD PMID:29621561 miconazole decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Miconazole results in decreased activity of CYP2C9 protein CTD PMID:15328084 midazolam decreases activity EXP 6480464 Midazolam results in decreased activity of CYP2C9 protein CTD PMID:18420780 mono(2-ethyl-5-hydroxyhexyl) phthalate multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate and [CYP2C9 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate CTD PMID:22186153 and PMID:23545481 mono(2-ethyl-5-oxohexyl) phthalate multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate and [CYP2C9 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate CTD PMID:22186153 and PMID:23545481 mono(2-ethylhexyl) phthalate increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate and CYP2C9 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate CTD PMID:22186153 and PMID:23545481 mono(2-ethylhexyl) phthalate multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of 2-ethyl-5-carboxypentyl phthalate more ... CTD PMID:22186153 and PMID:23545481 mono(5-carboxy-2-ethylpentyl) phthalate multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of 2-ethyl-5-carboxypentyl phthalate CTD PMID:23545481 monosodium L-glutamate multiple interactions EXP 6480464 [Sodium Glutamate co-treated with Tea] affects the expression of CYP2C9 mRNA CTD PMID:25663641 myricetin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 myricetin results in decreased activity of CYP2C9 protein CTD PMID:29753067 N,N-diethyl-m-toluamide increases expression ISO CYP2C9 (Homo sapiens) 6480464 DEET results in increased expression of CYP2C9 mRNA CTD PMID:27091632 N,N-diethyl-m-toluamide multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2C9 mRNA CTD PMID:27091632 N-acetyl-L-cysteine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Acetylcysteine affects the reaction [CYP2C9 protein results in increased hydroxylation of bromfenac] CTD PMID:31815452 N-desmethylclozapine increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of norclozapine CTD PMID:18809730 NADP zwitterion multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid more ... CTD PMID:16978661 more ... NADP(+) multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid more ... CTD PMID:16978661 more ... naphthalene increases expression ISO CYP2C9 (Homo sapiens) 6480464 naphthalene results in increased expression of CYP2C9 mRNA CTD PMID:20500019 naproxen multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Amiodarone promotes the reaction [CYP2C9 protein affects the metabolism of Naproxen] more ... CTD PMID:15130760 and PMID:16081671 naproxen increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Naproxen CTD PMID:11901091 more ... naproxen affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the metabolism of Naproxen and CYP2C9 protein affects the metabolism of Naproxen CTD PMID:11901091 and PMID:16081671 naproxen decreases methylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein polymorphism results in decreased methylation of Naproxen and CYP2C9 protein results in decreased methylation of Naproxen CTD PMID:15130760 naringin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 naringin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 nateglinide affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of nateglinide CTD PMID:18159128 nefazodone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CYP2C9 mRNA CTD PMID:33819548 nicardipine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Nicardipine results in decreased activity of CYP2C9 protein CTD PMID:10805063 and PMID:15863898 niclosamide increases activity ISO CYP2C9 (Homo sapiens) 6480464 Niclosamide results in increased activity of CYP2C9 protein CTD PMID:11124226 niclosamide multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Niclosamide promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] CTD PMID:14557374 nifedipine decreases activity EXP 6480464 Nifedipine results in decreased activity of CYP2C9 protein CTD PMID:18420780 nimesulide increases glutathionylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased glutathionylation of nimesulide CTD PMID:26524229 Notopterol increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of notopterol CTD PMID:32198085 Notopterol multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein results in increased metabolism of notopterol] promotes the reaction [Glutathione binds to notopterol] CTD PMID:32198085 O-methyleugenol decreases expression ISO CYP2C9 (Homo sapiens) 6480464 methyleugenol results in decreased expression of CYP2C9 mRNA CTD PMID:32234424 obeticholic acid decreases expression ISO CYP2C9 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of CYP2C9 mRNA CTD PMID:27939613 ochratoxin A increases expression ISO CYP2C9 (Homo sapiens) 6480464 ochratoxin A results in increased expression of CYP2C9 mRNA CTD PMID:21834667 ochratoxin A increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased susceptibility to ochratoxin A CTD PMID:21781659 and PMID:8542584 okanin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 okanin results in decreased activity of CYP2C9 protein CTD PMID:29753067 oleic acid multiple interactions EXP 6480464 PPARA protein promotes the reaction [Oleic Acid results in increased expression of CYP2C65 mRNA] CTD PMID:18489776 omeprazole multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Omeprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] CTD PMID:15258107 omeprazole decreases activity EXP 6480464 Omeprazole results in decreased activity of CYP2C9 protein CTD PMID:18420780 oxalic acid increases expression ISO CYP2C9 (Homo sapiens) 6480464 Oxalic Acid results in increased expression of CYP2C9 mRNA CTD PMID:37414240 oxalic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in increased expression of CYP2C9 mRNA] more ... CTD PMID:37414240 p-menthan-3-ol increases expression ISO CYP2C9 (Homo sapiens) 6480464 Menthol results in increased expression of CYP2C9 mRNA CTD PMID:24594507 p-tert-Amylphenol increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene SNP results in increased susceptibility to 4-tert-octylphenol CTD PMID:23555028 paclitaxel decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Paclitaxel results in decreased activity of CYP2C9 protein CTD PMID:19909766 paclitaxel increases activity ISO CYP2C9 (Homo sapiens) 6480464 Paclitaxel results in increased activity of CYP2C9 protein CTD PMID:19202563 pantoprazole multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 pantoprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] CTD PMID:15258107 paracetamol increases expression ISO CYP2C9 (Homo sapiens) 6480464 Acetaminophen results in increased expression of CYP2C9 mRNA CTD PMID:22230336 paracetamol multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C9 mRNA CTD PMID:33819548 paracetamol decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CYP2C9 mRNA CTD PMID:29067470 parathion affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Parathion CTD PMID:17079358 parathion increases expression ISO CYP2C9 (Homo sapiens) 6480464 Parathion results in increased expression of CYP2C9 mRNA CTD PMID:26196221 pedalitin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 pedalitin results in decreased activity of CYP2C9 protein CTD PMID:29753067 penconazole affects binding ISO CYP2C9 (Homo sapiens) 6480464 penconazole binds to CYP2C9 protein alternative form CTD PMID:29621561 pentamidine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Pentamidine results in decreased activity of CYP2C9 protein CTD PMID:11124226 perazine affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the metabolism of Perazine CTD PMID:11026737 perazine decreases methylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in decreased methylation of Perazine CTD PMID:11026737 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of CYP2C65 mRNA CTD PMID:28558994 perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of CYP2C65 mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2C65 mRNA more ... CTD PMID:20936131 and PMID:36331819 perfluorooctane-1-sulfonic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 perfluorooctane sulfonic acid inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] CTD PMID:21964418 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CYP2C65 mRNA CTD PMID:20936131 perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of CYP2C65 mRNA CTD PMID:18281256 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP2C65 mRNA CTD PMID:20936131 and PMID:28558994 perfluorooctanoic acid multiple interactions EXP 6480464 PPARA protein inhibits the reaction [perfluorooctanoic acid results in increased expression of CYP2C65 mRNA] CTD PMID:20936131 phencyclidine affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Phencyclidine CTD PMID:16782764 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP2C65 mRNA CTD PMID:23091169 phenobarbital decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Phenobarbital results in decreased activity of CYP2C9 protein CTD PMID:19909766 phenobarbital increases expression ISO CYP2C9 (Homo sapiens) 6480464 Phenobarbital results in increased expression of CYP2C9 mRNA and Phenobarbital results in increased expression of CYP2C9 protein CTD PMID:15629111 more ... phenobarbital affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the metabolism of Phenobarbital CTD PMID:17304159 phenobarbital increases activity ISO CYP2C9 (Homo sapiens) 6480464 Phenobarbital results in increased activity of CYP2C9 mRNA and Phenobarbital results in increased activity of CYP2C9 protein CTD PMID:19202563 and PMID:19328226 phenobarbital multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA] more ... CTD PMID:15802389 more ... phenprocoumon affects response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the susceptibility to Phenprocoumon CTD PMID:18698879 phenprocoumon increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Phenprocoumon CTD PMID:19082874 phenthoate decreases activity ISO CYP2C9 (Homo sapiens) 6480464 phenthoate results in decreased activity of CYP2C9 protein CTD PMID:22634058 phenthoate multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 phenthoate inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] CTD PMID:22634058 phenytoin decreases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism results in decreased hydroxylation of Phenytoin CTD PMID:16873909 and PMID:9860067 phenytoin increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Phenytoin CTD PMID:10208645 more ... phenytoin increases expression ISO CYP2C9 (Homo sapiens) 6480464 Phenytoin results in increased expression of CYP2C9 mRNA CTD PMID:14600250 phenytoin increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of Phenytoin CTD PMID:16873909 more ... phenytoin affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Phenytoin and CYP2C9 protein alternative form affects the metabolism of Phenytoin CTD PMID:15855726 more ... phenytoin increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism results in increased susceptibility to Phenytoin CTD PMID:11740344 phenytoin increases activity ISO CYP2C9 (Homo sapiens) 6480464 Phenytoin results in increased activity of CYP2C9 protein CTD PMID:19202563 phenytoin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Clozapine results in decreased activity of CYP2C9 protein] which results in increased susceptibility to Phenytoin more ... CTD PMID:14600250 more ... phenytoin decreases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 5' UTR polymorphism results in decreased metabolism of Phenytoin and CYP2C9 gene polymorphism results in decreased metabolism of Phenytoin CTD PMID:10208645 more ... phthalic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of phthalic acid CTD PMID:23545481 picoxystrobin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 picoxystrobin results in decreased activity of CYP2C9 protein CTD PMID:23611293 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP2C65 mRNA and PPARA protein inhibits the reaction [pirinixic acid results in increased expression of CYP2C65 mRNA] CTD PMID:18467677 and PMID:18489776 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CYP2C65 mRNA CTD PMID:17426115 and PMID:18467677 piroxicam affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the metabolism of Piroxicam CTD PMID:11901091 piroxicam multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Piroxicam inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] CTD PMID:16081671 piroxicam increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Piroxicam CTD PMID:11901091 more ... poly(styrene) multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP2C9 protein] CTD PMID:19909766 poly(styrene) decreases activity ISO CYP2C9 (Homo sapiens) 6480464 styrofoam analog results in decreased activity of CYP2C9 protein CTD PMID:19909766 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of CYP2C65 mRNA CTD PMID:23608068 potassium hexacyanoferrate(3-) multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 potassium ferricyanide affects the reaction [methysticin results in decreased activity of CYP2C9 protein] CTD PMID:35583123 profenofos multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 profenofos inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] CTD PMID:22634058 profenofos decreases activity ISO CYP2C9 (Homo sapiens) 6480464 profenofos results in decreased activity of CYP2C9 protein CTD PMID:22634058 progesterone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:21768169 propanal decreases expression ISO CYP2C9 (Homo sapiens) 6480464 propionaldehyde results in decreased expression of CYP2C9 mRNA CTD PMID:26079696 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP2C65 mRNA CTD PMID:19010342 more ... propranolol increases oxidation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased oxidation of Propranolol CTD PMID:19853591 pyrimethamine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Pyrimethamine results in decreased activity of CYP2C9 protein CTD PMID:11124226 quercetin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Quercetin inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] and Quercetin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CTD PMID:21053930 and PMID:24120545 quercetin increases expression ISO CYP2C9 (Homo sapiens) 6480464 Quercetin results in increased expression of CYP2C9 mRNA CTD PMID:21632981 quercetin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Quercetin results in decreased activity of CYP2C9 protein CTD PMID:18420780 and PMID:29753067 quinidine decreases activity EXP 6480464 Quinidine results in decreased activity of CYP2C9 protein CTD PMID:18420780 quinine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Quinine results in decreased activity of CYP2C9 protein CTD PMID:11124226 quinine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Quinine inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] CTD PMID:16081671 resveratrol multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP2C9 mRNA and Resveratrol inhibits the reaction [CYP2C9 protein results in increased metabolism of Losartan] CTD PMID:20716633 and PMID:23557933 resveratrol decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Resveratrol results in decreased activity of CYP2C9 protein CTD PMID:18420780 and PMID:30394306 Rhein decreases activity ISO CYP2C9 (Homo sapiens) 6480464 rhein results in decreased activity of CYP2C9 protein CTD PMID:27633141 and PMID:33438235 rifampicin increases activity ISO CYP2C9 (Homo sapiens) 6480464 Rifampin results in increased activity of CYP2C9 protein CTD PMID:14722322 more ... rifampicin affects response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 alternative form affects the susceptibility to Rifampin CTD PMID:36789833 rifampicin increases expression ISO CYP2C9 (Homo sapiens) 6480464 Rifampin results in increased expression of CYP2C9 mRNA and Rifampin results in increased expression of CYP2C9 protein CTD PMID:14600250 more ... rifampicin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Ketoconazole inhibits the reaction [Rifampin results in increased expression of CYP2C9 mRNA] more ... CTD PMID:14600250 more ... ritonavir increases expression ISO CYP2C9 (Homo sapiens) 6480464 Ritonavir results in increased expression of CYP2C9 mRNA CTD PMID:11918509 ritonavir increases activity ISO CYP2C9 (Homo sapiens) 6480464 Ritonavir results in increased activity of CYP2C9 protein CTD PMID:19202563 rubiadin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 rubiadin results in decreased activity of CYP2C9 protein CTD PMID:33438235 sertraline multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in decreased methylation of and results in increased metabolism of Sertraline and Sertraline inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] CTD PMID:15547048 and PMID:16081671 Shikonin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 shikonin results in decreased activity of CYP2C9 protein CTD PMID:28941798 silibinin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Silybin results in decreased activity of CYP2C9 protein CTD PMID:15155549 silicon dioxide decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of CYP2C9 mRNA CTD PMID:25895662 simvastatin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Simvastatin affects the reaction [CYP2C9 polymorphism affects the susceptibility to Warfarin] CTD PMID:22594507 sirolimus increases expression ISO CYP2C9 (Homo sapiens) 6480464 Sirolimus results in increased expression of CYP2C9 mRNA CTD PMID:25929522 sirolimus decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Sirolimus results in decreased expression of CYP2C9 protein CTD PMID:25929522 sodium arsenite decreases expression ISO CYP2C9 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CYP2C9 mRNA CTD PMID:29301061 sophoranone decreases activity ISO CYP2C9 (Homo sapiens) 6480464 sophoranone results in decreased activity of CYP2C9 protein CTD PMID:29753067 sorafenib decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Sorafenib metabolite results in decreased activity of CYP2C9 protein and Sorafenib results in decreased activity of CYP2C9 protein CTD PMID:33556367 sporidesmin A increases expression ISO CYP2C9 (Homo sapiens) 6480464 sporidesmin results in increased expression of CYP2C9 mRNA CTD PMID:28193462 steviol multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 steviol binds to and results in decreased activity of CYP2C9 protein CTD PMID:28887089 stevioside decreases expression ISO CYP2C9 (Homo sapiens) 6480464 stevioside results in decreased expression of CYP2C9 mRNA CTD PMID:28887089 Sudan I increases oxidation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased oxidation of 1-phenylazo-2-naphthol CTD PMID:17159775 sulfadiazine increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of Sulfadiazine CTD PMID:15843491 sulfaphenazole multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in increased expression of CYP2C9 mRNA] more ... CTD PMID:10991840 more ... sulfaphenazole decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Sulfaphenazole results in decreased activity of CYP2C9 protein CTD PMID:12464242 more ... sulfaphenazole increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Sulfaphenazole CTD PMID:17702393 and PMID:19309152 sulfaphenazole decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Sulfaphenazole results in decreased expression of CYP2C9 mRNA CTD PMID:24519941 sulfinpyrazone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Sulfinpyrazone inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] CTD PMID:16081671 Sunset Yellow FCF multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C9 mRNA CTD PMID:33819548 tamoxifen multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Tamoxifen CTD PMID:23397584 tamoxifen decreases activity EXP 6480464 Tamoxifen results in decreased activity of CYP2C9 protein CTD PMID:18420780 tamoxifen increases activity ISO CYP2C9 (Homo sapiens) 6480464 Tamoxifen metabolite results in increased activity of CYP2C9 protein CTD PMID:29285606 tartrazine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2C9 mRNA CTD PMID:33819548 tebuconazole affects binding ISO CYP2C9 (Homo sapiens) 6480464 tebuconazole binds to CYP2C9 protein and tebuconazole binds to CYP2C9 protein alternative form CTD PMID:29621561 tenofovir disoproxil fumarate decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Tenofovir results in decreased activity of CYP2C9 protein CTD PMID:17162464 teriflunomide increases expression ISO CYP2C9 (Homo sapiens) 6480464 teriflunomide results in increased expression of CYP2C9 mRNA CTD PMID:30364229 testosterone decreases activity EXP 6480464 Testosterone results in decreased activity of CYP2C9 protein CTD PMID:18420780 thiabendazole decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Thiabendazole results in decreased activity of CYP2C9 protein CTD PMID:11124226 thiacloprid increases expression ISO CYP2C9 (Homo sapiens) 6480464 thiacloprid results in increased expression of CYP2C9 protein CTD PMID:32201337 thiacloprid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [clothianidin co-treated with thiacloprid] results in increased expression of CYP2C9 protein CTD PMID:32201337 Thiocoraline affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of thiocoraline CTD PMID:15122071 thioridazine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine CTD PMID:23397584 thioridazine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Thioridazine results in decreased activity of CYP2C9 protein CTD PMID:15135088 ticlopidine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased oxidation of and results in increased cleavage of Ticlopidine metabolite more ... CTD PMID:19170597 and PMID:21915887 ticlopidine decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Ticlopidine results in decreased activity of CYP2C9 protein CTD PMID:21915887 tienilic acid affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Ticrynafen CTD PMID:21321060 tienilic acid increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased susceptibility to Ticrynafen CTD PMID:28762043 tienilic acid decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Ticrynafen results in decreased activity of CYP2C9 protein CTD PMID:15860655 more ... tienilic acid multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [[Ticrynafen results in decreased activity of CYP2C9 protein] which affects the metabolism of Diclofenac] which affects the abundance of 4'-hydroxydiclofenac more ... CTD PMID:16049126 and PMID:31854189 tienilic acid increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Ticrynafen CTD PMID:12464242 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C65 mRNA CTD PMID:29950665 tolbutamide decreases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene SNP results in decreased hydroxylation of Tolbutamide CTD PMID:9170147 tolbutamide increases metabolic processing EXP 6480464 CYP2C65 protein results in increased metabolism of Tolbutamide CTD PMID:30503582 tolbutamide multiple interactions EXP 6480464 [CYP2C65 protein results in increased metabolism of Tolbutamide] which results in increased chemical synthesis of 4'-hydroxytolbutamide CTD PMID:30503582 tolbutamide increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of Tolbutamide CTD PMID:10611138 more ... tolbutamide decreases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism results in decreased metabolism of Tolbutamide CTD PMID:10208645 and PMID:9110362 tolbutamide increases hydrolysis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydrolysis of Tolbutamide CTD PMID:11377097 tolbutamide affects hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the hydroxylation of Tolbutamide CTD PMID:9170147 tolbutamide affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the metabolism of Tolbutamide more ... CTD PMID:11875364 more ... tolbutamide increases chemical synthesis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased chemical synthesis of Tolbutamide metabolite CTD PMID:23850985 tolbutamide increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Tolbutamide CTD PMID:10208645 more ... tolbutamide multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP2C9 protein results in increased metabolism of Tolbutamide] which results in increased chemical synthesis of 4'-hydroxytolbutamide more ... CTD PMID:10611138 more ... torasemide increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Torsemide CTD PMID:19082874 torasemide increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of Torsemide CTD PMID:9110362 trans-cinnamic acid decreases activity ISO CYP2C9 (Homo sapiens) 6480464 cinnamic acid analog results in decreased activity of CYP2C9 protein CTD PMID:15072549 tranylcypromine multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP2C65 mRNA CTD PMID:23970803 triclosan increases expression ISO CYP2C9 (Homo sapiens) 6480464 Triclosan results in increased expression of CYP2C22 mRNA and Triclosan results in increased expression of CYP2C9 mRNA CTD PMID:29849464 triflumuron increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of triflumuron CTD PMID:31082524 triptonide increases expression EXP 6480464 triptonide results in increased expression of CYP2C65 mRNA CTD PMID:33045310 troglitazone decreases activity ISO CYP2C9 (Homo sapiens) 6480464 troglitazone results in decreased activity of CYP2C9 protein CTD PMID:12642470 troglitazone multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to troglitazone CTD PMID:23397584 tryptamines decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Tryptamines analog results in decreased activity of CYP2C9 protein CTD PMID:26599973 tryptamines multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 [Tryptamines analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac CTD PMID:26599973 valproic acid decreases expression ISO CYP2C9 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CYP2C9 mRNA CTD PMID:29154799 and PMID:29501571 valproic acid increases expression ISO CYP2C9 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CYP2C9 mRNA CTD PMID:25084468 valproic acid increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 polymorphism results in increased susceptibility to Valproic Acid CTD PMID:20398172 valproic acid increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Valproic Acid CTD PMID:16945988 and PMID:20602621 valsartan affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 polymorphism affects the metabolism of Valsartan CTD PMID:34998819 verapamil decreases activity EXP 6480464 Verapamil results in decreased activity of CYP2C9 protein CTD PMID:18420780 vincristine increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene SNP results in increased susceptibility to Vincristine CTD PMID:21245421 vitamin K multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the reaction [Vitamin K affects the susceptibility to Warfarin] CTD PMID:27462768 voriconazole decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Voriconazole results in decreased activity of CYP2C9 protein CTD PMID:15328084 and PMID:15914520 voriconazole affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the metabolism of Voriconazole CTD PMID:15914520 warfarin increases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene mutant form results in increased susceptibility to Warfarin more ... CTD PMID:11794436 more ... warfarin increases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydroxylation of Warfarin CTD PMID:11455026 more ... warfarin decreases activity ISO CYP2C9 (Homo sapiens) 6480464 Warfarin results in decreased activity of CYP2C9 protein CTD PMID:18420780 warfarin increases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased metabolism of Warfarin CTD PMID:12464242 more ... warfarin increases hydrolysis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein results in increased hydrolysis of Warfarin CTD PMID:9698079 warfarin affects abundance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the abundance of Warfarin CTD PMID:25986145 warfarin decreases metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism results in decreased metabolism of Warfarin CTD PMID:20073138 warfarin affects hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 protein affects the hydroxylation of Warfarin CTD PMID:10613612 warfarin decreases response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism results in decreased susceptibility to Warfarin CTD PMID:18030307 and PMID:18034619 warfarin decreases hydroxylation ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism results in decreased hydroxylation of Warfarin CTD PMID:11455026 warfarin affects hydrolysis ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 gene polymorphism affects the hydrolysis of Warfarin CTD PMID:9698079 warfarin affects metabolic processing ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 enhancer polymorphism affects the metabolism of Warfarin more ... CTD PMID:11307788 more ... warfarin multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 10-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] more ... CTD PMID:10613612 more ... warfarin affects response to substance ISO CYP2C9 (Homo sapiens) 6480464 CYP2C9 affects the susceptibility to Warfarin more ... CTD PMID:11127854 more ... zafirlukast decreases activity ISO CYP2C9 (Homo sapiens) 6480464 zafirlukast results in decreased activity of CYP2C9 protein CTD PMID:15370959 zafirlukast multiple interactions ISO CYP2C9 (Homo sapiens) 6480464 zafirlukast inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] and zafirlukast inhibits the reaction [CYP2C9 protein results in increased metabolism of Tolbutamide] CTD PMID:15370959 and PMID:16081671 zoledronic acid increases expression ISO CYP2C9 (Homo sapiens) 6480464 zoledronic acid results in increased expression of CYP2C9 mRNA CTD PMID:24714768